Navigating MolDx, Z-Codes and Prior Authorization to Help Labs Stay Ahead
Lab Reimbursement Strategies for Molecular and Genetic Testing
Category: For Laboratories
Discover the latest news, trends, and best practices in revenue cycle management for lab and diagnostic providers, including coding, billing, and collections.
Navigating MolDx, Z-Codes and Prior Authorization to Help Labs Stay Ahead
The Future of Molecular Testing Reimbursement
Reimbursement for molecular and genetic testing is more complex than ever. With shifting MolDx policies, evolving payer guidelines, and growing prior authorization requirements, laboratories must stay proactive to safeguard revenue and maintain compliance.
In this on-demand webinar, industry experts Ann Lambrix and Tara Cepull break down the latest payer expectations, upcoming regulatory changes, and actionable strategies to minimize denials and optimize reimbursement
Smarter Lab Billing with AI: How Automation Drives Profitability
Forward-thinking labs are using AI, RPA, and smart workflows to reduce admin burden, improve accuracy, and unlock new revenue cycle efficiencies.
Leading Through Change: Ensuring Billing Stability for Labs
Avoid billing delays and disruptions with a strong plan during leadership transitions.
PAMA Reform: The Introduction of the RESULTS Act Legislation
BLOG>
What the new legislation could mean for labs, providers, and the future of diagnostic testing.
Beyond the Deal: RCM Pitfalls That Can Undermine Lab M&A Success
Ensure success by addressing critical RCM integration pitfalls that can disrupt post-close performance and erode confidence.
The End of an Era: FDA is Rescinding Long-Contested LDT Rule for Labs
Withdrawal of LDT Rule Provides Regulatory Clarity and Reimbursement Guidance for Laboratories
UnitedHealth Group’s Turmoil: The Impact on Labs and Pathology Groups
Rising costs, regulatory scrutiny, and shifting payer dynamics could reshape lab and pathology practice operations and reimbursements.
From Red Flags to Readiness: How Labs Can Stay Ahead of Audit Risks
With $1.2B in improper lab payments projected, payers are ramping up audits—putting clinical labs under intense scrutiny.
Labs Under the Microscope: Staying Ready for Payer Audits
Payer audits are increasing—Medicare TPEs, UPIC probes, and commercial pre-payment reviews are putting labs under more scrutiny than ever. In this 60-minute on-demand session, learn what revenue cycle leaders need to know in 2025 to reduce audit risk, spot common triggers, and respond effectively. We share real-world audit scenarios, key questions to ask your RCM vendor, and how the right partner can help protect your billing operations.